Are These 3 Under $1 Penny Stocks Worth Buying in 2022?
If you’re looking for the best penny stocks to buy right now, there are hundreds of under $1 options to choose from. While the term penny stocks itself simply implies any stock trading under $5, many investors look for those under the $1 mark. However, this price point typically implies high volatility which is usually driven by speculation. With penny stocks, these are both normal, however, as we go lower in price, we tend to see the two rise.
While neither speculation nor volatility are worth getting fearful about, they should help to identify what your strategy should be moving forward. And right now, having a proper trading strategy is the best thing you can do to have a higher chance of making money with penny stocks. As we all know, the Omicron variant is one of, if not the main source of movement in the stock market.
And while 2022 is a new year, we are still dealing with the ramifications of the pandemic. So, keep your ear to the ground and work to understand how certain events will impact industries and the penny stocks on your watchlist. With that in mind, let’s take a look at three under $1 penny stocks to watch right now.
3 Penny Stocks to Add to Your Under $1 Watchlist Right Now
Oragenics Inc. (NYSE: OGEN)
One of the bigger gainers of the day so far is Oragenics Inc., pushing up by over 16% at midday. This brings its five day gain to almost 20%, which is no small feat. The reason behind today’s gain for OGEN comes as a Form 4 filing showed that Director Robert Koski had purchased 1 million shares of OGEN stock at around $0.47 per share. While this alone is not major news, insider buys can often spark both retail and institutional confidence in a company. And, they can signal that there could be an event on the horizon.
In addition to this, a few weeks ago, Oragenics announced the extension of its collaboration with NRC Canada for an Omicron-specific Covid vaccine. The company previously showed that its Terra-CoV-2 candidate showed protection against Covid-19 in hamsters. It’s vaccine was also tested for both intramuscular and intranasal protection, and provided robust viral load reduction. Now, Oragenics plans to file an IND application with the FDA by the second quarter of 2022.
While it is hard to say what the long term plan for OGEN stock is, we do know that it is quite volatile right now. But, with the high amount of positivity surrounding biotech penny stocks, it could be worth keeping an eye on. Considering that, will OGEN be on your list of penny stocks to watch?
Farmmi Inc. (NASDAQ: FAMI)
Another big gainer of the day so far is FAMI stock, pushing up by over 9% at midday. Despite a one year drop of around 77%, we have begun to see a slight bullish turnaround for FAMI stock in the past few trading days. The bulk of the momentum with Farmmi comes from two unique factors. On one hand, the company is often heavily affected by its placement as a meme penny stock. This means that it’s price fluctuates greatly based on how trending it is online.
On the other hand, Farmmi has landed several decent sales orders in the past few months. The most recent of these came last week when it announced that its subsidiary, Zhejiang Farmmi Biotechnology Co. Ltd., won a repeat order for export to Southampton, England.
“This is another important win for us. It continues the meaningful sales growth trajectory we have been building all year as we leverage our increased investments in sales and marketing to build our global brand, and it also benefited from our consistent product availability due to our strong supply chain relationships.”
The CEO of Farmmi, Ms. Yefang Zhang
If you’re not familiar, Farmmi is a producer of edible fungi products. This includes Mu Er mushrooms, Shiitake’s and more. With its solid momentum in the past few weeks, does FAMI stock deserve a spot on your penny stocks watchlist moving forward?
TherapeuticsMD Inc. (NASDAQ: TXMD)
Another major gainer of the day so far is TXMD stock, which shot up by over 23% at midday. In the past month, shares have climbed by around 27%, which is no small feat and reflects the company’s announcements during that time.
The most recent of these came today when it received FDA approval for a low-dose version of BIJUVA, an oral hormone therapy to treat women with vasomotor syndrome due to menopause. While commercialization efforts are still in talks, this is without a doubt, an exciting prospect for the company. A few weeks ago, the company also announced that it will continue to supply ANNOVERA in compliance with manufacturing testing limits.
The President of TherapeuticsMD, Hugh O’Dowd stated “The Company will continue to manufacture and supply ANNOVERA under the existing specification and will work with the FDA to address their comments.” As a women-focused biotech company, TherapeuticsMD is working on the commercialization of these products which includes reproductive health, menopause management and more. So, with that in mind, is TXMD stock worth buying right now?
Are Penny Stocks Worth Buying This Year?
If you’re looking for the best penny stocks to buy, there are hundreds of options to choose from. Although it may seem difficult to pick given the sheer number of factors that are impacting the market right now, with research, it can be much easier. As always, penny stocks are both highly volatile and speculative. This means that prices will move by large amounts and on a regular basis.
So to benefit from this, investors need to have both a thorough trading strategy and a consistent understanding of where the market is headed. While Covid may not be around forever, we will likely see some lasting effects from the pandemic for quite some time. Considering all of this, do you think that penny stocks are worth buying this year or not?
If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!